Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/1999
08/12/1999CA2327545A1 Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob
08/12/1999CA2321175A1 Method of screening therapeutic agents
08/12/1999CA2320470A1 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media
08/12/1999CA2320144A1 Neokine protein and nucleic acid molecules and uses therefor
08/12/1999CA2320098A1 Compositions and methods to inhibit formation of the c5b-9 complex of complement
08/12/1999CA2319764A1 Costimulatory blockade and mixed chimerism in transplantation
08/12/1999CA2319644A1 Human serine protease and serpin polypeptides
08/12/1999CA2319448A1 Costimulatory blockade and mixed chimerism in allotransplantation
08/12/1999CA2319236A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
08/12/1999CA2319097A1 Dendritic enriched secreted lymphocyte activation molecule
08/12/1999CA2318977A1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
08/12/1999CA2317478A1 Benzofuran-4-carboxamides and their therapeutic use
08/12/1999CA2317476A1 Hydroxamic and carboxylic acid derivatives
08/12/1999CA2316860A1 Three-dimensional structures and models of fc receptors and uses thereof
08/12/1999CA2286174A1 Benzyloxy prodigiosine compounds
08/11/1999EP0934937A1 Azole derivatives as superoxide radical inhibitor
08/11/1999EP0934931A2 3-Benzylidene-2-indolinones and their analogues as tyrosine kinase activity modulators
08/11/1999EP0934747A1 Reverse transcriptase inhibitor from Ulmus Hollandica
08/11/1999EP0934408A1 Nucleic acid encoding ds-cam proteins and products related thereto
08/11/1999EP0934340A1 Novel compounds
08/11/1999EP0934335A1 Novel compounds
08/11/1999EP0934318A1 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
08/11/1999EP0934317A2 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
08/11/1999EP0934309A1 New pyridyl alkane acid amides as cytostatics and immunosuppressives
08/11/1999EP0934307A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
08/11/1999EP0934304A1 2-pyrimidineamine derivatives and processes for their preparation
08/11/1999EP0934300A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/11/1999EP0934290A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same
08/11/1999EP0934280A1 Pde iv inhibiting 2-cyanoiminoimidazole derivatives
08/11/1999EP0934068A1 Compounds and methods
08/11/1999EP0756605B1 Peptides as therapeutic agents for the treatment of auto-immune diseases
08/11/1999EP0725651B1 Hemoregulatory peptides
08/11/1999EP0701572B1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv
08/11/1999EP0646132B1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use
08/11/1999EP0584223B1 Novel immunosuppressive compounds
08/11/1999EP0584185B1 Treatment of fatigue syndrome with cholinesterase inhibitors
08/11/1999CN1225682A Method and compositions for regulating T cell subsets by modulating transcription facter activity
08/11/1999CN1225637A Pyrrole triazines and pyrimidines
08/11/1999CN1225629A Novel pyrrole derivatives
08/11/1999CN1225556A Animal feed
08/11/1999CN1225367A Bond partner, and use for sieving inhibitor and diagnosis and treatment of disease
08/11/1999CN1225360A Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them
08/11/1999CN1225275A Turnip oral liquor and process for preparing same
08/10/1999US5936066 Recombinant human interleukin-1α
08/10/1999US5935995 Poly-, oligo- and monosaccharides of drugs, e.g. nitrogen mustard gas, quinine and dipyridamole; stability; slow release; antiarthitic agents; enzyme inhibitors
08/10/1999US5935982 Methods of treating retroviral infection and compounds useful therefor
08/10/1999US5935972 Benzofuran derivatives as tachykinin antagonists
08/10/1999US5935956 Pyridazine compounds
08/10/1999US5935931 Human apoptosis-related calcium-binding protein
08/10/1999US5935929 Methods for treating interstitial lung disease by using interleukin-9 and its antagonists
08/10/1999US5935865 Semaphorin gene family
08/10/1999US5935814 G-protein coupled receptor family polypeptides, referred to as hfgan72y, altered nucleic acid seqences encoding it and recombinant materials and methods for its production; use in design of protocols and treatment of various infections
08/10/1999US5935803 Methods to identify immunomodulators using cognate interaction of PKC-theta
08/10/1999US5935585 Novel compounds useful in topical and systemic treatment of dermatological conditions associated with a keratinization disorder, and inflammatory or immunoallergenic component; body and hair care cosmetics
08/10/1999US5935577 Treatment of autoimmune disease using tolerization in combination with methotrexate
08/10/1999US5935576 Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
08/10/1999US5935575 Interleukin-4 stimulated T lymphocyte cell death for the treatment of allergic disorders
08/10/1999US5935568 Gene therapy for effector cell regulation
08/10/1999US5935565 Method for increasing the level of stem cells in peripheral blood
08/10/1999CA2126863C Chimeric immunogens
08/10/1999CA2093434C Regulation of immunoglobulin production by interleukin-9
08/10/1999CA1340704C Human interferon-gamma, process to prepare said human interferon-gamma, and its use
08/05/1999WO1999038954A1 A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use
08/05/1999WO1999038868A1 Azolo triazines and pyrimidines
08/05/1999WO1999038843A1 Hydroxamic and carboxylic acid derivatives
08/05/1999WO1999038829A1 Novel tricyclic compound
08/05/1999WO1999038532A2 Methods for the prevention and treatment of fibrosis and sclerosis
08/05/1999WO1999038531A1 TREATING ATOPIC DERMATITIS WITH IgE ANTAGONISTS
08/05/1999WO1999038530A1 Agent capable of modulating a glycosphingolipid-associated activity thus affecting an immune disorder
08/05/1999WO1999038528A2 Vaccine formulations
08/05/1999WO1999038526A1 Variant peptide ligands that selectively induce apoptosis
08/05/1999WO1999038523A1 CYTOKINE INDUCERS COMPRISING M161Ag
08/05/1999WO1999038514A1 Cyclic amine modulators of chemokine receptor activity
08/05/1999WO1999038492A1 Nasal solutions
08/05/1999WO1999038380A1 Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness
08/05/1999WO1999028493A3 Method for identifying inhibitors of g-protein coupled receptor hibef51
08/05/1999WO1999022766A3 Use of anti-il-12 antibodies in transplantation rejection
08/05/1999WO1999020643A9 Using polyamide nucleic acid oligomers to engender a biological response
08/05/1999WO1999014322A3 Allelic variant of human stat3
08/05/1999WO1997003664A8 Use of ipriflavone to reduce the number of cd8+ cells
08/05/1999CA2319781A1 Cyclic amine modulators of chemokine receptor activity
08/05/1999CA2319711A1 Vaccine
08/05/1999CA2318336A1 Methods for the prevention and treatment of fibrosis and sclerosis
08/05/1999CA2318190A1 Agent capable of modulating a glycosphingolipid-associated activity thus affecting an immune disorder
08/04/1999EP0933366A1 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same
08/04/1999EP0933351A1 Tricyclic retinoids, methods for their production and use
08/04/1999EP0933350A1 Tricyclic retinoids, methods for their production and use
08/04/1999EP0933346A1 NOVEL p-TERPHENYL COMPOUNDS
08/04/1999EP0932626A1 G protein-coupled receptor antagonists
08/04/1999EP0932623A1 Colostrinin, and uses thereof
08/04/1999EP0932618A1 Peptide analogues containing a 7-membered lactam ring
08/04/1999EP0932415A1 Method of preventing acute rejection following solid organ transplantation
08/04/1999EP0932411A1 Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
08/04/1999EP0932410A1 Mistletoe (viscum) extracts
08/04/1999EP0932399A1 Water soluble paclitaxel prodrugs
08/04/1999EP0932397A2 Medicinal aerosol formulations comprising budesonide
08/04/1999EP0759027B1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
08/04/1999EP0744957B1 Composition and method for preventing and treating inflammation with immunoglobulin a
08/04/1999EP0740653B1 Hydroxamic acid derivatives as metalloproteinase inhibitors
08/04/1999CN1224720A Tetracylic derivatives, process of preparation and use
1 ... 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 ... 1172